Protein kinases and the proteasome join in the combinatorial control of transcription by nuclear retinoic acid receptors

Trends in Cell Biology

Volumn 17, Issue 6, 2007, Pages 302-309

  Bour, Gaétan ^a   Lalevée, Sébastien ^a   Rochette Egly, Cécile ^a  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE; PROTEIN TYROSINE KINASE; PROTEIN VINEXIN BETA; RETINOIC ACID RECEPTOR; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; CHROMATIN IMMUNOPRECIPITATION; DIMERIZATION; GENE ACTIVATION; GENE EXPRESSION; GENE TARGETING; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CELL NUCLEUS; CYCLIN-DEPENDENT KINASES; CYCLINS; GENE EXPRESSION REGULATION; HUMANS; MAP KINASE SIGNALING SYSTEM; MODELS, MOLECULAR; MUSCLE PROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN CONFORMATION; PROTEIN KINASES; RECEPTORS, RETINOIC ACID; TRANSCRIPTION FACTOR TFIIH; TRANSCRIPTION, GENETIC;

EID: 34249751092     PISSN: 09628924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcb.2007.04.003     Document Type: Review

References (62)

1. Germain P., et al. Overview of nomenclature of nuclear receptors. Pharmacol. Rev. 58 (2006) 685-704
2. Germain P., et al. International Union of Pharmacology. LX. Retinoic acid receptors. Pharmacol. Rev. 58 (2006) 712-725
3. Germain P., et al. International Union of Pharmacology. LXIII. Retinoid X receptors. Pharmacol. Rev. 58 (2006) 760-772
4. Bour G., et al. Mouse embryocarcinoma F9 cells and retinoic acid. A model to study the molecular mechanisms of endodermal differentiation. In: Taneja R. (Ed). Nuclear Receptors in Development Vol. 16 (2006), Elsevier Press Inc. 211-253
5. Germain P., et al. Nuclear receptor superfamily: principles of signaling. Pure Appl. Chem. 75 (2003) 1619-1664
6. Bastien J., and Rochette-Egly C. Nuclear Retinoid receptors and the transcription of retinoid-target genes. Gene 328 (2004) 1-16
7. Lefebvre P., et al. Transcriptional activities of retinoic acid receptors. Vitam. Horm. 70 (2005) 199-264
8. Steinmetz A.C., et al. Binding of ligands and activation of transcription by nuclear receptors. Annu. Rev. Biophys. Biomol. Struct. 30 (2001) 329-359
9. Egea P.F., et al. Effects of ligand binding on the association properties and conformation in solution of retinoic acid receptors RXR and RAR. J. Mol. Biol. 307 (2001) 557-576
10. Glass C.K., and Rosenfeld M.G. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. 14 (2000) 121-141
11. Dilworth F.J., and Chambon P. Nuclear receptors coordinate the activities of chromatin remodeling complexes and coactivators to facilitate initiation of transcription. Oncogene 20 (2001) 3047-3054
12. Rochette-Egly C. Dynamic combinatorial networks in nuclear receptor-mediated transcription. J. Biol. Chem. 280 (2005) 32565-32568
13. Rosenfeld M.G., et al. Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. Genes Dev. 20 (2006) 1405-1428
14. Pavri R., et al. PARP-1 determines specificity in a retinoid signaling pathway via direct modulation of mediator. Mol. Cell 18 (2005) 83-96
15. Perissi V., et al. A corepressor/coactivator exchange complex required for transcriptional activation by nuclear receptors and other regulated transcription factors. Cell 116 (2004) 511-526
16. Flajollet S., et al. Distinct roles of the steroid receptor coactivator 1 and of MED1 in retinoid-induced transcription and cellular differentiation. J. Biol. Chem. 281 (2006) 20338-20348
17. Elmlund H., et al. The cyclin-dependent kinase 8 module sterically blocks Mediator interactions with RNA polymerase II. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 15788-15793
18. Andrau J.C., et al. Genome-wide location of the coactivator mediator: Binding without activation and transient Cdk8 interaction on DNA. Mol. Cell 22 (2006) 179-192
19. Laine J.P., et al. TFIIH enzymatic activities in transcription and nucleotide excision repair. Methods Enzymol. 408 (2006) 246-263
20. Lavery D.N., and McEwan I.J. Structure and function of steroid receptor AF1 transactivation domains: induction of active conformations. Biochem. J. 391 (2005) 449-464
21. Warnmark A., et al. Activation functions 1 and 2 of nuclear receptors: molecular strategies for transcriptional activation. Mol. Endocrinol. 17 (2003) 1901-1909
22. Dyson H.J., and Wright P.E. Intrinsically unstructured proteins and their functions. Nat. Rev. Mol. Cell Biol. 6 (2005) 197-208
23. Liu J., et al. Intrinsic disorder in transcription factors. Biochemistry 45 (2006) 6873-6888
24. Rochette-Egly C. Nuclear receptors: integration of multiple signalling pathways through phosphorylation. Cell. Signal. 15 (2003) 355-366
25. Bastien J., et al. TFIIH interacts with the retinoic acid receptor gamma and phosphorylates its AF-1-activating domain through CDK7. J. Biol. Chem. 275 (2000) 21896-21904
26. Keriel A., et al. XPD Mutations prevent TFIIH-dependent transactivation by nuclear receptors and phosphorylation of RARα. Cell 109 (2002) 125-135
27. Gaillard E., et al. Phosphorylation by protein kinase A potentiates retinoic acid repeptor a activity by means of increasing interaction with and phosphorylation by cyclin H/CDK7. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 9548-9553
28. Bour G., et al. Cyclin H binding to the RARα activation function (AF)-2 domain directs phosphorylation of the AF-1 domain by cyclin-dependent kinase 7. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 16608-16613
29. Bao L., et al. Prevalent overexpression of prolyl isomerase Pin1 in human cancers. Am. J. Pathol. 164 (2004) 1727-1737
30. Brondani V., et al. The peptidyl-prolyl isomerase Pin1 regulates phospho-Ser77 retinoic acid receptor alpha stability. Biochem. Biophys. Res. Commun. 328 (2005) 6-13
31. Bour G., et al. Vinexin β interacts with the non-phosphorylated AF-1 domain of retinoid receptor γ (RARγ) and represses RARγ-mediated transcription. J. Biol. Chem. 280 (2005) 17027-17037
32. Kioka N., et al. Vinexin, CAP/ponsin, ArgBP2: a novel adaptor protein family regulating cytoskeletal organization and signal transduction. Cell Struct. Funct. 27 (2002) 1-7
33. Archer S.K., et al. Evolution of the gelsolin family of actin-binding proteins as novel transcriptional coactivators. Bioessays 27 (2005) 388-396
34. Gettemans J., et al. Nuclear actin-binding proteins as modulators of gene transcription. Traffic 6 (2005) 847-857
35. Wu X., et al. Regulation of RNA-polymerase-II-dependent transcription by N-WASP and its nuclear-binding partners. Nat. Cell Biol. 8 (2006) 756-763
36. Tujague M., et al. The focal adhesion protein vinexin α regulates the phosphorylation and activity of estrogen receptor α. J. Biol. Chem. 279 (2004) 9255-9263
37. Boonyaratanakornkit V., et al. Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases. Mol. Cell 8 (2001) 269-280
38. Manavathi B., et al. An inherent role of microtubule network in the action of nuclear receptor. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 15981-15986
39. Bettinger B.T., et al. Actin up in the nucleus. Nat. Rev. Mol. Cell Biol. 5 (2004) 410-415
40. Hofmann W.A., et al. Actin is part of pre-initiation complexes and is necessary for transcription by RNA polymerase II. Nat. Cell Biol. 6 (2004) 1094-1101
41. Wang I.F., et al. Actin-based modeling of a transcriptionally competent nuclear substructure induced by transcription inhibition. Exp. Cell Res. 312 (2006) 3796-3807
42. Mitsushima M., et al. Protein kinase A-dependent increase in WAVE2 expression induced by the focal adhesion protein vinexin. Genes Cells 11 (2006) 281-292
43. Mitsushima M., et al. Abl kinase interacts with and phosphorylates vinexin. FEBS Lett. 580 (2006) 4288-4295
44. Gianni M., et al. Phosphorylation by p38MAPK and recruitment of SUG-1 are required for RA-induced RARγ degradation and transactivation. EMBO J. 21 (2002) 3760-3769
45. Gianni M., et al. P38MAPK-dependent phosphorylation and degradation of SRC-3/AIB1 and RARα-mediated transcription. EMBO J. 25 (2006) 739-751
46. Yi P., et al. Peptidyl-prolyl isomerase 1 (Pin1) serves as a coactivator of steroid receptor by regulating the activity of phosphorylated steroid receptor coactivator 3 (SRC-3/AIB1). Mol. Cell. Biol. 25 (2005) 9687-9699
47. Wu R.C., et al. Transcriptional regulation by steroid receptor coactivator phosphorylation. Endocr. Rev. 26 (2005) 393-399
48. Dennis A.P., and O'Malley B.W. Rush hour at the promoter: how the ubiquitin-proteasome pathway polices the traffic flow of nuclear receptor-dependent transcription. J. Steroid Biochem. Mol. Biol. 93 (2005) 139-151
49. Kopf E., et al. Dimerization with retinoid X receptors and phosphorylation modulate the retinoic acid-induced degradation of retinoic acid receptors α and γ through the ubiquitin-proteasome pathway. J. Biol. Chem. 275 (2000) 33280-33288
50. Glickman M.H., and Ciechanover A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol. Rev. 82 (2002) 373-428
51. Verma R., et al. Multiubiquitin chain receptors define a layer of substrate selectivity in the ubiquitin-proteasome system. Cell 118 (2004) 99-110
52. Tansey W.P. Transcriptional activation: risky business. Genes Dev. 15 (2001) 1045-1050
53. Collins G.A., and Tansey W.P. The proteasome: a utility tool for transcription?. Curr. Opin. Genet. Dev. 16 (2006) 197-202
54. Lipford J.R., and Deshaies R.J. Diverse roles for ubiquitin-dependent proteolysis in transcriptional activation. Nat. Cell Biol. 5 (2003) 845-850
55. Muratani M., and Tansey W.P. How the ubiquitin-proteasome system controls transcription. Nat. Rev. Mol. Cell Biol. 4 (2003) 192-201
56. Lee D., et al. The proteasome regulatory particle alters the SAGA coactivator to enhance its interactions with transcriptional activators. Cell 123 (2005) 423-436
57. Ezhkova E., and Tansey W.P. Proteasomal ATPases link ubiquitylation of histone H2B to methylation of histone H3. Mol. Cell 13 (2004) 435-442
58. vom Baur E., et al. Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1. EMBO J. 15 (1996) 110-124
59. Bardelli A., et al. Mutational analysis of the tyrosine kinome in colorectal cancers. Science 300 (2003) 949
60. Blume-Jensen P., and Hunter T. Oncogenic kinase signalling. Nature 411 (2001) 355-365
61. Neri L.M., et al. The phosphoinositide 3-kinase/AKT1 pathway involvement in drug and all-trans-retinoic acid resistance of leukemia cells. Mol. Cancer Res. 1 (2003) 234-246
62. Tari A.M., et al. Her2/neu induces all-trans retinoic acid (ATRA) resistance in breast cancer cells. Oncogene 21 (2002) 5224-5232